NVE CORP /NEW/ — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that NVE CORP /NEW/ filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $25.87M | May 7, 2025 |
| FY2025 | Mar 31, 2024 | $29.80M | May 7, 2025 |
| FY2024 | Mar 31, 2023 | $38.25M | May 1, 2024 |
| FY2023 | Mar 31, 2022 | $26.99M | May 3, 2023 |
| FY2020 | Mar 31, 2020 | $25.41M | May 6, 2020 |
| FY2020 | Mar 31, 2019 | $26.47M | May 6, 2020 |
| FY2019 | Mar 31, 2018 | $29.86M | May 1, 2019 |
| FY2018 | Mar 31, 2017 | $28.33M | May 2, 2018 |
| FY2018 | Mar 31, 2016 | $27.72M | May 2, 2018 |
| FY2017 | Mar 31, 2015 | $30.58M | May 4, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $21.64M | May 7, 2025 |
| FY2025 | Mar 31, 2024 | $23.03M | May 7, 2025 |
| FY2024 | Mar 31, 2023 | $30.19M | May 1, 2024 |
| FY2023 | Mar 31, 2022 | $20.72M | May 3, 2023 |
| FY2022 | Mar 31, 2021 | $17.24M | May 4, 2022 |
| FY2021 | Mar 31, 2020 | $20.52M | May 5, 2021 |
| FY2020 | Mar 31, 2019 | $21.26M | May 6, 2020 |
| FY2019 | Mar 31, 2018 | $23.59M | May 1, 2019 |
| FY2018 | Mar 31, 2017 | $22.25M | May 2, 2018 |
| FY2018 | Mar 31, 2016 | $21.10M | May 2, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $15.06M | May 7, 2025 |
| FY2025 | Mar 31, 2024 | $17.12M | May 7, 2025 |
| FY2024 | Mar 31, 2023 | $22.69M | May 1, 2024 |
| FY2023 | Mar 31, 2022 | $14.51M | May 3, 2023 |
| FY2022 | Mar 31, 2021 | $11.69M | May 4, 2022 |
| FY2021 | Mar 31, 2020 | $14.53M | May 5, 2021 |
| FY2020 | Mar 31, 2019 | $14.51M | May 6, 2020 |
| FY2019 | Mar 31, 2018 | $13.91M | May 1, 2019 |
| FY2018 | Mar 31, 2017 | $12.95M | May 2, 2018 |
| FY2018 | Mar 31, 2016 | $12.29M | May 2, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $15.99M | May 7, 2025 |
| FY2025 | Mar 31, 2024 | $18.52M | May 7, 2025 |
| FY2024 | Mar 31, 2023 | $25.64M | May 1, 2024 |
| FY2023 | Mar 31, 2022 | $16.33M | May 3, 2023 |
| FY2022 | Mar 31, 2021 | $12.74M | May 4, 2022 |
| FY2021 | Mar 31, 2020 | $15.51M | May 5, 2021 |
| FY2020 | Mar 31, 2019 | $15.92M | May 6, 2020 |
| FY2019 | Mar 31, 2018 | $18.45M | May 1, 2019 |
| FY2018 | Mar 31, 2017 | $17.45M | May 2, 2018 |
| FY2018 | Mar 31, 2016 | $16.29M | May 2, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $3.64M | May 7, 2025 |
| FY2025 | Mar 31, 2024 | $2.73M | May 7, 2025 |
| FY2024 | Mar 31, 2023 | $2.58M | May 1, 2024 |
| FY2023 | Mar 31, 2022 | $2.93M | May 3, 2023 |
| FY2022 | Mar 31, 2021 | $3.18M | May 4, 2022 |
| FY2021 | Mar 31, 2020 | $3.69M | May 5, 2021 |
| FY2020 | Mar 31, 2019 | $4.11M | May 6, 2020 |
| FY2019 | Mar 31, 2018 | $3.70M | May 1, 2019 |
| FY2018 | Mar 31, 2017 | $3.34M | May 2, 2018 |
| FY2018 | Mar 31, 2016 | $3.06M | May 2, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Mar 31, 2022 | $1.47M | May 4, 2022 |
| FY2022 | Mar 31, 2021 | $1.32M | May 4, 2022 |
| FY2021 | Mar 31, 2020 | $1.32M | May 5, 2021 |
| FY2020 | Mar 31, 2019 | $1.22M | May 6, 2020 |
| FY2019 | Mar 31, 2018 | $1.44M | May 1, 2019 |
| FY2018 | Mar 31, 2017 | $1.46M | May 2, 2018 |
| FY2018 | Mar 31, 2016 | $1.75M | May 2, 2018 |
| FY2017 | Mar 31, 2015 | $2.31M | May 4, 2017 |
| FY2016 | Mar 31, 2014 | $2.24M | May 4, 2016 |
| FY2015 | Mar 31, 2013 | $2.24M | May 6, 2015 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $14.31M | May 7, 2025 |
| FY2025 | Mar 31, 2024 | $18.25M | May 7, 2025 |
| FY2024 | Mar 31, 2023 | $19.09M | May 1, 2024 |
| FY2023 | Mar 31, 2022 | $12.50M | May 3, 2023 |
| FY2022 | Mar 31, 2021 | $13.36M | May 4, 2022 |
| FY2021 | Mar 31, 2020 | $15.90M | May 5, 2021 |
| FY2020 | Mar 31, 2019 | $14.22M | May 6, 2020 |
| FY2019 | Mar 31, 2018 | $15.15M | May 1, 2019 |
| FY2018 | Mar 31, 2017 | $12.38M | May 2, 2018 |
| FY2018 | Mar 31, 2016 | $14.31M | May 2, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $1.26M | May 7, 2025 |
| FY2025 | Mar 31, 2024 | $16.7K | May 7, 2025 |
| FY2024 | Mar 31, 2023 | $935.8K | May 1, 2024 |
| FY2023 | Mar 31, 2022 | $484.6K | May 3, 2023 |
| FY2022 | Mar 31, 2021 | $62.7K | May 4, 2022 |
| FY2021 | Mar 31, 2020 | $52.0K | May 5, 2021 |
| FY2020 | Mar 31, 2019 | $68.3K | May 6, 2020 |
| FY2019 | Mar 31, 2018 | $604.8K | May 1, 2019 |
| FY2018 | Mar 31, 2017 | $519.8K | May 2, 2018 |
| FY2018 | Mar 31, 2016 | $287.3K | May 2, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $64.28M | May 7, 2025 |
| FY2025 | Mar 31, 2024 | $66.78M | May 7, 2025 |
| FY2024 | Mar 31, 2023 | $69.26M | May 1, 2024 |
| FY2023 | Mar 31, 2022 | $67.47M | May 3, 2023 |
| FY2022 | Mar 31, 2021 | $72.50M | May 4, 2022 |
| FY2021 | Mar 31, 2020 | $79.50M | May 5, 2021 |
| FY2020 | Mar 31, 2019 | $83.62M | May 6, 2020 |
| FY2019 | Mar 31, 2018 | $87.43M | May 1, 2019 |
| FY2018 | Mar 31, 2017 | $93.77M | May 2, 2018 |
| FY2017 | Mar 31, 2016 | $100.85M | May 4, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $2.01M | May 7, 2025 |
| FY2025 | Mar 31, 2024 | $1.21M | May 7, 2025 |
| FY2024 | Mar 31, 2023 | $2.18M | May 1, 2024 |
| FY2023 | Mar 31, 2022 | $2.90M | May 3, 2023 |
| FY2022 | Mar 31, 2021 | $1.61M | May 4, 2022 |
| FY2021 | Mar 31, 2020 | $1.50M | May 5, 2021 |
| FY2020 | Mar 31, 2019 | $835.7K | May 6, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $62.27M | May 7, 2025 |
| FY2025 | Mar 31, 2024 | $65.57M | May 7, 2025 |
| FY2024 | Mar 31, 2023 | $67.08M | May 1, 2024 |
| FY2023 | Mar 31, 2022 | $64.57M | May 3, 2023 |
| FY2022 | Mar 31, 2021 | $70.89M | May 4, 2022 |
| FY2022 | Mar 31, 2020 | $78.00M | May 4, 2022 |
| FY2021 | Mar 31, 2019 | $82.78M | May 5, 2021 |
| FY2020 | Mar 31, 2018 | $86.44M | May 6, 2020 |
| FY2018 | Mar 31, 2017 | $92.68M | May 2, 2018 |
| FY2017 | Mar 31, 2016 | $99.26M | May 4, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $42.47M | May 7, 2025 |
| FY2025 | Mar 31, 2024 | $46.74M | May 7, 2025 |
| FY2024 | Mar 31, 2023 | $48.95M | May 1, 2024 |
| FY2023 | Mar 31, 2022 | $45.58M | May 3, 2023 |
| FY2022 | Mar 31, 2021 | $50.40M | May 4, 2022 |
| FY2021 | Mar 31, 2020 | $58.05M | May 5, 2021 |
| FY2020 | Mar 31, 2019 | $62.90M | May 6, 2020 |
| FY2019 | Mar 31, 2018 | $67.71M | May 1, 2019 |
| FY2018 | Mar 31, 2017 | $73.16M | May 2, 2018 |
| FY2017 | Mar 31, 2016 | $79.56M | May 4, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $8.04M | May 7, 2025 |
| FY2025 | Mar 31, 2024 | $10.28M | May 7, 2025 |
| FY2024 | Mar 31, 2023 | $1.67M | May 1, 2024 |
| FY2023 | Mar 31, 2022 | $10.45M | May 3, 2023 |
| FY2022 | Mar 31, 2021 | $10.43M | May 4, 2022 |
| FY2021 | Mar 31, 2020 | $8.07M | May 5, 2021 |
| FY2020 | Mar 31, 2019 | $6.88M | May 6, 2020 |
| FY2020 | Mar 31, 2018 | $4.76M | May 6, 2020 |
| FY2019 | Mar 31, 2017 | $8.20M | May 1, 2019 |
| FY2018 | Mar 31, 2016 | $7.53M | May 2, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 3 | May 7, 2025 |
| FY2025 | Mar 31, 2024 | 3 | May 7, 2025 |
| FY2024 | Mar 31, 2023 | 4 | May 1, 2024 |
| FY2023 | Mar 31, 2022 | 3 | May 3, 2023 |
| FY2022 | Mar 31, 2021 | 2 | May 4, 2022 |
| FY2021 | Mar 31, 2020 | 3 | May 5, 2021 |
| FY2020 | Mar 31, 2019 | 3 | May 6, 2020 |
| FY2019 | Mar 31, 2018 | 2 | May 1, 2019 |
| FY2018 | Mar 31, 2017 | 2 | May 2, 2018 |
| FY2018 | Mar 31, 2016 | 2 | May 2, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 3 | May 7, 2025 |
| FY2025 | Mar 31, 2024 | 3 | May 7, 2025 |
| FY2024 | Mar 31, 2023 | 4 | May 1, 2024 |
| FY2023 | Mar 31, 2022 | 3 | May 3, 2023 |
| FY2022 | Mar 31, 2021 | 2 | May 4, 2022 |
| FY2021 | Mar 31, 2020 | 3 | May 5, 2021 |
| FY2020 | Mar 31, 2019 | 2 | May 6, 2020 |
| FY2019 | Mar 31, 2018 | 2 | May 1, 2019 |
| FY2018 | Mar 31, 2017 | 2 | May 2, 2018 |
| FY2018 | Mar 31, 2016 | 2 | May 2, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 4.84M | May 7, 2025 |
| FY2025 | Mar 31, 2024 | 4.83M | May 7, 2025 |
| FY2024 | Mar 31, 2023 | 4.83M | May 1, 2024 |
| FY2023 | Mar 31, 2022 | 4.83M | May 3, 2023 |
| FY2022 | Mar 31, 2021 | 4.83M | May 4, 2022 |
| FY2021 | Mar 31, 2020 | 4.84M | May 5, 2021 |
| FY2020 | Mar 31, 2019 | 4.85M | May 6, 2020 |
| FY2019 | Mar 31, 2018 | 4.84M | May 1, 2019 |
| FY2018 | Mar 31, 2017 | 4.84M | May 2, 2018 |
| FY2017 | Mar 31, 2016 | 4.84M | May 4, 2017 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Mar 31, 2022 | $19.33M | May 4, 2022 |
| FY2022 | Mar 31, 2021 | $19.34M | May 4, 2022 |
| FY2021 | Mar 31, 2020 | $19.38M | May 5, 2021 |
| FY2020 | Mar 31, 2019 | $19.37M | May 6, 2020 |
| FY2019 | Mar 31, 2018 | $19.37M | May 1, 2019 |
| FY2018 | Mar 31, 2017 | $19.35M | May 2, 2018 |
| FY2018 | Mar 31, 2016 | $19.41M | May 2, 2018 |
| FY2017 | Mar 31, 2015 | $10.00M | May 4, 2017 |
| FY2015 | Mar 31, 2014 | $0 | May 6, 2015 |
| FY2015 | Mar 31, 2013 | $0 | May 6, 2015 |